|
|
|
|
|
|
|
Atyr Pharma Inc (LIFE)
|
|
2.4 -0.05 (-2.04%)
|
04-20 16:00
|
|
Open:
|
2.45
|
Pre. Close:
|
2.45
|
|
High:
|
2.45
|
Low:
|
2.35
|
|
Volume:
|
43,321
|
Market Cap:
|
72M
|
|
|
|
Stock Price Prediction (Update at 5:00pm est.)
|
|
If
tomorrow:
|
Open
lower
|
Open
higher
|
|
High:
|
2.455 - 2.469
|
2.469 - 2.484
|
|
Low:
|
2.312 - 2.327
|
2.327 - 2.343
|
|
Close:
|
2.371 - 2.398
|
2.398 - 2.427
|
|
|
|
Technical analysis (as of: 2018-04-20 4:31:28 PM)
|
|
Overall:
|
|
|
Stoxline posted a SELL today, same as yesterday. This stock seems to continue bearish move. So you may continue to hold short positions or sell your long positions. You are relatively safe to short or sell now, downward move is expected.
|
|
Target:
|
Six months: 3.29  One year: 3.62
|
|
Support:
|
Support1: 2.35 Support2: 1.96
|
|
Resistance:
|
Resistance1:
2.81 Resistance2: 3.10
|
|
Pivot:
|
2.64
|
|
Moving Averages:
|
MA(5): 2.52 MA(20): 2.69
MA(100): 3.36 MA(250): 3.57
|
|
MACD:
|
MACD(12,26):
-0.13 Signal(12,26,9): -0.11
|
|
%K %D:
|
%K(14,3): 8.33  %D(3): 8.81
|
|
RSI:
|
RSI(14): 28.70
|
|
52-Week:
|
High: 6.496
Low: 2.3 Change(%): -23.8
|
|
Average Vol(K):
|
3-Month: 4852
10-Days 2504
|
|
|
|
|
|
★
Strong Sell
★★
Sell ★★★
Neutral
★★★★
Buy
★★★★★
Strong Buy
|
|
|
Price, moving averages and
Bollinger Bands
|
|
Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and BEARISH in mid-long term.LIFE has closed below the lower band by 7.9%. If price is in a downtrend band; this downward trend in price might continue. However a short term pullback inside the band is likely. Bollinger Bands are 27.1% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
|
|
|
Headline News
|
|
2018-03-19T22:25:06-04:00
aTyr Pharma's (LIFE) CEO Dr. Sanjay Shukla on Q4 2017 Results - Earnings Call Transcript
2018-03-19T16:09:44-04:00
aTyr Pharma beats by $0.02
2018-02-22T11:53:40-05:00
Tracking Ole Andreas Halvorsen's Viking Global Portfolio - Q4 2017 Update
2018-02-14T08:57:10-05:00
Premarket analyst action - healthcare
2018-01-11T14:14:09-05:00
aTyr Pharma (LIFE) Presents At 36th Annual J.P. Morgan Healthcare Conference - Slideshow
2017-11-21T03:22:06-05:00
Tracking Ole Andreas Halvorsen's Viking Global Portfolio - Q3 2017 Update
2017-09-30T18:11:03-04:00
Faison's Weekend Review And Scans
2017-09-26T13:32:14-04:00
aTyr Pharma (LIFE) Presents At Ladenburg Thalmann 2017 Healthcare Conference - Slideshow
|
|
|
Financial Analysis
|
|
Growth
|
|
|
Growth measures the growth of both a company's revenue
and net income. it tells investors how fast a company is growing.
|
|
Profitability
|
|
|
Profitability measures a company’s ability to
generate earnings as compared to its expenses
and other relevant costs.
|
|
Solvency
|
|
|
Solvency measures a company's ability to meet its long-term debts.
Acceptable solvency ratios will vary from industry to industry.
|
|
Efficiency
|
NA
|
|
Efficiency measures the strength of a company's return on invested capital.
It can identify business that are better managed or not.
|
|
Click here to get more fundamental analysis.
|
|
